Infective endocarditis resident survival guide: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) (→Do's) |
||
Line 277: | Line 277: | ||
* Consider alternative diagnoses for [[bacteremia]] and [[fever]]. | * Consider alternative diagnoses for [[bacteremia]] and [[fever]]. | ||
* Initiate antibiotic therapy after withdrawing blood for culture (Class I, level of evidence B).<ref name="circ.ahajournals.org">{{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher = | date = | accessdate = 4 March 2014 }}</ref> | * Initiate antibiotic therapy after withdrawing blood for culture (Class I, level of evidence B).<ref name="circ.ahajournals.org">{{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher = | date = | accessdate = 4 March 2014 }}</ref> | ||
* If the blood cultures are negative in a patient suspected to have [[infective endocarditis]], suspect HACEK infection and ask the laboratory to retain the [[blood cultures]] for more than two weeks. | |||
* If the blood cultures are negative in a patient suspected to have [[infective endocarditis]], suspect HACEK infection and ask the laboratory to retain the [[blood cultures]] for more than two weeks.<ref name="Baddour-2005">{{Cite journal | last1 = Baddour | first1 = LM. | last2 = Wilson | first2 = WR. | last3 = Bayer | first3 = AS. | last4 = Fowler | first4 = VG. | last5 = Bolger | first5 = AF. | last6 = Levison | first6 = ME. | last7 = Ferrieri | first7 = P. | last8 = Gerber | first8 = MA. | last9 = Tani | first9 = LY. | title = Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. | journal = Circulation | volume = 111 | issue = 23 | pages = e394-434 | month = Jun | year = 2005 | doi = 10.1161/CIRCULATIONAHA.105.165564 | PMID = 15956145 }}</ref> | |||
* If HACEK bacteremia is detected without any focus of infection, suspect the presence of infective endocarditis even in the absence of the typical signs and symptoms.<ref name="Baddour-2005">{{Cite journal | last1 = Baddour | first1 = LM. | last2 = Wilson | first2 = WR. | last3 = Bayer | first3 = AS. | last4 = Fowler | first4 = VG. | last5 = Bolger | first5 = AF. | last6 = Levison | first6 = ME. | last7 = Ferrieri | first7 = P. | last8 = Gerber | first8 = MA. | last9 = Tani | first9 = LY. | title = Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. | journal = Circulation | volume = 111 | issue = 23 | pages = e394-434 | month = Jun | year = 2005 | doi = 10.1161/CIRCULATIONAHA.105.165564 | PMID = 15956145 }}</ref> | |||
* Do a [[TEE]] intraoperatively among patients scheduled for valve surgery for infective endocarditis (Class I, level of evidence B).<ref name="circ.ahajournals.org">{{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher = | date = | accessdate = 4 March 2014 }}</ref> | * Do a [[TEE]] intraoperatively among patients scheduled for valve surgery for infective endocarditis (Class I, level of evidence B).<ref name="circ.ahajournals.org">{{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher = | date = | accessdate = 4 March 2014 }}</ref> | ||
* Consider ordering a cardiac CT scan when echocardiography does not provide clear details about the cardiac anatomy in the context of suspected paravalvular infections (Class IIa, level of evidence B).<ref name="circ.ahajournals.org">{{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher = | date = | accessdate = 4 March 2014 }}</ref> | * Consider ordering a cardiac CT scan when echocardiography does not provide clear details about the cardiac anatomy in the context of suspected paravalvular infections (Class IIa, level of evidence B).<ref name="circ.ahajournals.org">{{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.citation | publisher = | date = | accessdate = 4 March 2014 }}</ref> | ||
Revision as of 16:23, 5 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farman Khan, MD, MRCP [2]; Mohamed Moubarak, M.D. [3]; Rim Halaby, M.D. [4]
Definition
Infective endocarditis is the infection of the endothelium of the heart including but not limited to the valves. While acute bacterial endocarditis is caused by an infection with a virulent organism such as staphylococcus aureus, group A or other beta-hemolytic streptococci, subacute bacterial endocarditis is an indolent infection with less virulent organisms like streptococcus viridans.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Endocarditis can be a life-threatening condition if it is left untreated, and it must be treated as such irrespective of the causes.
Common Causes
Management
Shown below is an algorithm depicting the management of infective endocarditis.[1][2]
Characterize the symptoms:
❑ Onset of the symptoms
❑ Fever | |||||||||||||||||||||||
Identify existing risk factors: ❑ History of rheumatic heart disease
| |||||||||||||||||||||||
Examine the patient:
Skin ❑ Petechiae Dental examination Eyes ❑ Conjunctival hemorrhage Heart Lungs ❑ Rales as a sign of heart failure Abdomen ❑ Reduced bowel sounds (sign of mesenteric embolization or ileus)
Extremities ❑ Janeway lesions (painless hemorrhagic cutaneous lesions on the palms and soles) Neurologic ❑ Full neurological exam
| |||||||||||||||||||||||
Does the patient have any of the following: ❑ Unexplained fever for more than 48 hours and high risk for infective endocarditis
❑ Newly diagnosed valve regurgitation | |||||||||||||||||||||||
Order tests: ❑ Blood culture (at least two sets)
| |||||||||||||||||||||||
Evaluate the Modified Duke Criteria for infective endocarditis:[3]
| |||||||||||||||||||||||
❑ Begin antibiotic treatment (look below for details)
❑ Schedule early surgery during hospitalization before completion of the antibiotics course in case of
❑ Remove the pacemaker of the defibrillator system in case of
| |||||||||||||||||||||||
❑ Consult an infectious disease specialist ❑ Consult a cardiologist ❑ Consult a cardiac surgeon | |||||||||||||||||||||||
Reevaluate the patient with TTE and/or TEE
❑ Change in clinical signs and symptoms
❑ High risk of complications
| |||||||||||||||||||||||
Modified Duke Criteria
Shown below is a table summarizing the major and minor Modified Duke Criteria.
Major criteria | Minor criteria |
1- Positive Blood Culture for Infective Endocarditis ❑ Typical microorganism consistent with infective endocarditis from 2 separate blood cultures, in the absence of a primary focus:
2-Echocardiographic evidence of endocardial involvement |
1- Predisposition ❑ Predisposing heart condition or intravenous drug use 2- Fever 3- Vascular phenomena 4- Immunologic phenomena 5- Microbiological evidence |
Prophylaxis
Shown below an algorithm depicting the general prophylactic approaches of infective endocarditis.[4][1]
Identify high risk patients: (Class IIa, Level of evidence B)
❑ Prosthetic valves patients
| |||||||||||||||||||||||||||||||||||||||||
Identify high risk procedures:
❑ Procedures on infected skin or musculoskeletal tissue | |||||||||||||||||||||||||||||||||||||||||
Do's
- Elicit a full medical history to help detecting the minor Duke criteria for the diagnosis.
- Consider alternative diagnoses for bacteremia and fever.
- Initiate antibiotic therapy after withdrawing blood for culture (Class I, level of evidence B).[1]
- If the blood cultures are negative in a patient suspected to have infective endocarditis, suspect HACEK infection and ask the laboratory to retain the blood cultures for more than two weeks.[2]
- If HACEK bacteremia is detected without any focus of infection, suspect the presence of infective endocarditis even in the absence of the typical signs and symptoms.[2]
- Do a TEE intraoperatively among patients scheduled for valve surgery for infective endocarditis (Class I, level of evidence B).[1]
- Consider ordering a cardiac CT scan when echocardiography does not provide clear details about the cardiac anatomy in the context of suspected paravalvular infections (Class IIa, level of evidence B).[1]
Dont's
- Don't administer prophylaxis for infective endocarditis in patients with valvular heart disease who are at risk infective endocarditis for procedures such as TEE, cystoscopy, esophagogastroduodenoscopy or colonoscopy without any evidence of active infection (Class III; level of evidence B).[1]
- Do not administer infective endocarditis prophylaxis for the following dental procedures:
- Anesthetic injections in noninfected tissue
- Dental radiographs
- Shedding of deciduous teeth
- Placement of orthodontic brackets
- Placement or removal of prosthodontic or orthodontic appliances
- Adjustment of orthodontic appliances
- Bleeding following trauma to the oral mucosa or lips[5]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary". Retrieved 4 March 2014.
- ↑ 2.0 2.1 2.2 Baddour, LM.; Wilson, WR.; Bayer, AS.; Fowler, VG.; Bolger, AF.; Levison, ME.; Ferrieri, P.; Gerber, MA.; Tani, LY. (2005). "Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America". Circulation. 111 (23): e394–434. doi:10.1161/CIRCULATIONAHA.105.165564. PMID 15956145. Unknown parameter
|month=
ignored (help) - ↑ Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T; et al. (2000). "Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis". Clin Infect Dis. 30 (4): 633–8. doi:10.1086/313753. PMID 10770721.
- ↑ Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M; et al. (2007). "Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group". Circulation. 116 (15): 1736–54. doi:10.1161/CIRCULATIONAHA.106.183095. PMID 17446442.
- ↑ Bonow RO, Carabello BA, Chatterjee K; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172. Unknown parameter
|month=
ignored (help)